Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy (Q38100673)

28 August 2017

Biomarkers for predicting the response of esophageal squamous cell carcinoma to neoadjuvant chemoradiation therapy (English)

1 reference

esophageal squamous cell carcinoma

28 August 2017

0 references

0 references

1 reference

inferred from title

squamous cell carcinoma

1 reference

Hiroshi Okumura

1

1 reference

28 August 2017

Yasuto Uchikado

2

1 reference

28 August 2017

Tetsuro Setoyama

3

1 reference

28 August 2017

Masataka Matsumoto

4

1 reference

28 August 2017

Tetsuhiro Owaki

5

1 reference

28 August 2017

Sumiya Ishigami

6

1 reference

28 August 2017

Shoji Natsugoe

7

1 reference

28 August 2017

19 April 2013

1 reference

28 August 2017

1 reference

28 August 2017

44

1 reference

28 August 2017

3

1 reference

28 August 2017

421-428

1 reference

p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes

28 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Expression of angiogenic factors predicts response to chemoradiotherapy and prognosis of oesophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Cell-cycle regulators and the Ki-67 labeling index can predict the response to chemoradiotherapy and the survival of patients with locally advanced squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Clinical outcomes of enteroscopy using the double-balloon method for strictures of the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Using Q-RT-PCR to measure cyclin D1, TS, TP, DPD, and Her-2/neu as predictors for response, survival, and recurrence in patients with esophageal squamous cell carcinoma following radiochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

A dual-specificity phosphatase Cdc25B is an unstable protein and triggers p34(cdc2)/cyclin B activation in hamster BHK21 cells arrested with hydroxyurea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Inhibition of vascular endothelial growth factor receptor signaling in angiogenic tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Host cyclooxygenase-2 modulates carcinoma growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Hedgehog signaling in animal development: paradigms and principles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Sonic hedgehog regulates gastric gland morphogenesis in man and mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Correlation of hedgehog signal activation with chemoradiotherapy sensitivity and survival in esophageal squamous cell carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Patients with ERCC1-negative locally advanced esophageal cancers may benefit from preoperative chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Expression of p53R2 is related to prognosis in patients with esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-013-0580-Y

Enhanced apoptosis in metallothionein null cells

21 January 2018

1 reference

12 December 2020

p53 status and the efficacy of cancer therapy in vivo

1 reference

12 December 2020

P53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients

1 reference

12 December 2020

Predictive value of COX-2 for the effect of chemoradiotherapy on esophageal squamous cell carcinoma.

1 reference

12 December 2020

Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma

1 reference

12 December 2020

Immunohistochemical status of the p53 protein and Ki-67 antigen using biopsied specimens can predict a sensitivity to neoadjuvant therapy in patients with esophageal cancer

1 reference

12 December 2020

Overexpression of p53 protein associates decreased response to chemoradiotherapy in patients with esophageal carcinoma

1 reference

12 December 2020

Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information

1 reference

12 December 2020

Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma.

1 reference

12 December 2020

Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas

1 reference

12 December 2020

Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells.

1 reference

12 December 2020

p53 negativity, CDC25B positivity, and metallothionein negativity are predictors of a response of esophageal squamous cell carcinoma to chemoradiotherapy

1 reference

12 December 2020

p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint

1 reference

12 December 2020

Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation

1 reference

12 December 2020

The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma

1 reference

12 December 2020

Metallothionein expression correlates with the pathological response of patients with esophageal cancer undergoing preoperative chemoradiation therapy

1 reference

12 December 2020

Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution

1 reference

12 December 2020

Preoperative chemotherapy and radiotherapy for esophageal carcinoma

1 reference

12 December 2020

The cdc25B phosphatase is essential for the G2/M phase transition in human cells

1 reference

12 December 2020

Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy.

1 reference

12 December 2020

Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma

1 reference

12 December 2020

Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities

1 reference

12 December 2020

CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers

1 reference

12 December 2020

10.1007/S00595-013-0580-Y

Identifiers

DOI

1 reference

28 August 2017

1 reference